Musculoskeletal Flashcards
Zanaflex
tizanidine (PO)
Pharmacologic category: alpha2 agonist
Common indication: spasticity
Key side effects: drowsiness, hypotension, dizziness, xerostomia, weakness
Plaquenil
hydroxychloroquine (PO)
Pharmacologic category: aminoquinolone
Common indication: RA, SLE, malaria
Key side effects: retinal toxicity, rash, diarrhea
Other Notes: use has been associated with cardiomyopathy, bone marrow suppression, and neuromuscular effects (i.e., myopathy, palsies, and progressive weakness)
Colcrys
colchicine (PO)
Pharmacologic category: antigout agent
Common indication: gout
Key side effects: diarrhea, nausea, vomiting, bone marrow suppression, myotoxicity (including rhabdomyolysis)
Voltaren
diclofenac (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings; may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Motrin, Advil
ibuprofen (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Mobic
meloxicam (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Relafen
nabumetone (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Feldene
piroxicam (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Indocin
indomethacin (PO)
Pharmacologic category: NSAID
Common indication: OA, RA, acute pain, gout
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Toradol
ketorolac (PO, IV)
Pharmacologic category: NSAID
Common indication: Pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation; indicated for short term use (<= 5 days)
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Celebrex
celecoxib (PO)
Pharmacologic category: NSAID, COX-2 selective
Common indication: OA, RA, acute pain
Key side effects: diarrhea, dyspepsia, abdominal pain, flatulence, nausea
US Boxed Warnings: may increase the risk of serious (and potentially fatal) cardiovascular thrombotic events; may increase the risk for serious (and potentially fatal) gastrointestinal adverse events including ulceration, bleeding, and perforation
Other Notes: may reduce renal blood flow and compromise existing renal function (avoid in patients with renal disease, heart failure, and cirrhosis)
Voltaren Gel, Solareze
diclofenac (topical)
Pharmacologic category: NSAID
Common indication: OA
Key side effects: pruritis, rash
Flexeril
cyclobenzaprine (PO)
Pharmacologic category: skeletal muscle relaxant
Common indication: muscle spasm
Key side effects: drowsiness, dizziness, xerostomia, fatigue
Other Notes: use may cause prolonged cardiac arrhythmias, and tachycardia; CI within 14 days of MAOI inhibitor therapy
Lioresal
baclofen (PO)
Pharmacologic category: skeletal muscle relaxant
Common indication: spasticity
Key side effects: drowsiness
Soma
carisoprodol (PO)
Pharmacologic category: skeletal muscle relaxant
Common indication: muscle spasm
Key side effects: drowsiness
Other Notes: drug abuse potential